Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Donald Calne
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Chemicals & Drugs
Procedures
Anatomy
Concepts & Ideas
Sign-in to see full Profile
Network (preview)
40
Snow, BJ
37
Schulzer, Michael
33
Stoessl, Jon
32
Ruth, Thomas
27
Mak, Edwin
26
Wszolek, Zbigniew
17
Martin, Wayne
17
de La Fuente-Fernández, Raúl
16
Uitti, Ryan
14
Sossi, Vesna
13
McGeer, Patrick
11
Vingerhoets, FJ
11
LeWitt, Peter
10
Farrer, Matthew
10
Chu, Nai-Shin
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Donald Calne (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Nandhagopal R; Kuramoto L; Schulzer M; Mak E; Cragg J; Lee Chong S; McKenzie J; McCormick S; Samii A; Troiano A; Ruth T J; Sossi V; de la Fuente-Fernandez R; Calne Donald B; Stoessl A J
Longitudinal progression of sporadic Parkinson's disease: a multi-tracer positron emission tomography study.
Brain : a journal of neurology 2009;132(Pt 11):2970-9.
-
2009: Golub Yulia; Berg Daniela; Calne Donald B; Pfeiffer Ronald F; Uitti Ryan J; Stoessl A Jon; Wszolek Zbigniew K; Farrer Matthew J; Mueller Jakob C; Gasser Thomas; Fuchs Julia
Genetic factors influencing age at onset in LRRK2-linked Parkinson disease.
Parkinsonism & related disorders 2009;15(7):539-41.
-
2009: Wider Christian; Dickson Dennis W; Stoessl A Jon; Tsuboi Yoshio; Chapon Françoise; Gutmann Ludwig; Lechevalier Bernard; Calne Donald B; Personett David A; Hulihan Mary; Kachergus Jennifer; Rademakers Rosa; Baker Matthew C; Grantier Linda L; Sujith O K; Brown Laura; Calne Susan; Farrer Matthew J; Wszolek Zbigniew K
Pallidonigral TDP-43 pathology in Perry syndrome.
Parkinsonism & related disorders 2009;15(4):281-6.
-
2009: Farrer Matthew J; Hulihan Mary M; Kachergus Jennifer M; Dächsel Justus C; Stoessl A Jon; Grantier Linda L; Calne Susan; Calne Donald B; Lechevalier Bernard; Chapon Francoise; Tsuboi Yoshio; Yamada Tatsuo; Gutmann Ludwig; Elibol Bülent; Bhatia Kailash P; Wider Christian; Vilariño-Güell Carles; Ross Owen A; Brown Laura A; Castanedes-Casey Monica; Dickson Dennis W; Wszolek Zbigniew K
DCTN1 mutations in Perry syndrome.
Nature genetics 2009;41(2):163-5.
-
2007: Miklossy Judith; Qing Hong; Guo Jian-Ping; Yu Sheng; Wszolek Zbigniew K; Calne Donald; McGeer Edith G; McGeer Patrick L
Lrrk2 and chronic inflammation are linked to pallido-ponto-nigral degeneration caused by the N279K tau mutation.
Acta neuropathologica 2007;114(3):243-54.
-
2007: Melquist Stacey; Craig David W; Huentelman Matthew J; Crook Richard; Pearson John V; Baker Matt; Zismann Victoria L; Gass Jennifer; Adamson Jennifer; Szelinger Szabolcs; Corneveaux Jason; Cannon Ashley; Coon Keith D; Lincoln Sarah; Adler Charles; Tuite Paul; Calne Donald B; Bigio Eileen H; Uitti Ryan J; Wszolek Zbigniew K; Golbe Lawrence I; Caselli Richard J; Graff-Radford Neill; Litvan Irene; Farrer Matthew J; Dickson Dennis W; Hutton Mike; Stephan Dietrich A
Identification of a novel risk locus for progressive supranuclear palsy by a pooled genomewide scan of 500,288 single-nucleotide polymorphisms.
American journal of human genetics 2007;80(4):769-78.
-
2007: Huang C-C; Chu N-S; Lu C-S; Chen R-S; Schulzer M; Calne D B
The natural history of neurological manganism over 18 years.
Parkinsonism & related disorders 2007;13(3):143-5.
-
2006: Wszolek Z K; Baba Y; Mackenzie I R; Uitti R J; Strongosky A J; Broderick D F; Baker M C; Melquist S; Hutton M L; Tsuboi Y; Allanson J E; Carr J; Kumar A; Calne S M; Miklossy J; McGeer P L; Calne D B; Stoessl A J
Autosomal dominant dystonia-plus with cerebral calcifications.
Neurology 2006;67(4):620-5.
-
2005: Adams John R; van Netten Hinke; Schulzer Michael; Mak Edwin; Mckenzie Jessamyn; Strongosky Audrey; Sossi Vesna; Ruth Thomas J; Lee Chong S; Farrer Matthew; Gasser Thomas; Uitti Ryan J; Calne Donald B; Wszolek Zbigniew K; Stoessl A Jon
PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation.
Brain : a journal of neurology 2005;128(Pt 12):2777-85.
-
2005: Au Wing Lok; Calne Donald B
A reassessment of the Lewy body.
Acta neurologica Taiwanica 2005;14(2):40-7.
-
2005: Miklossy Judit; Mackenzie Ian R; Dorovini-Zis Katerina; Calne Donald B; Wszolek Zbigniew K; Klegeris Andis; McGeer Patrick L
Severe vascular disturbance in a case of familial brain calcinosis.
Acta neuropathologica 2005;109(6):643-53.
-
2005: Calne Donald
A definition of Parkinson's disease.
Parkinsonism & related disorders 2005;11 Suppl 1():S39-40.
-
2005: Calne Donald; Schulzer Michael; Mak Edwin; Stoessl A Jon
Treatment for the progression of Parkinson's disease.
Lancet neurology 2005;4(4):206.
-
2004: Oliveira J R M; Spiteri E; Sobrido M J; Hopfer S; Klepper J; Voit T; Gilbert J; Wszolek Z K; Calne D B; Stoessl A J; Hutton M; Manyam B V; Boller F; Baquero M; Geschwind D H
Genetic heterogeneity in familial idiopathic basal ganglia calcification (Fahr disease).
Neurology 2004;63(11):2165-7.
-
2004: Lee Chong S; Schulzer Michael; de la Fuente-Fernández Raúl; Mak Edwin; Kuramoto Lisa; Sossi Vesna; Ruth Thomas J; Calne Donald B; Stoessl A Jon
Lack of regional selectivity during the progression of Parkinson disease: implications for pathogenesis.
Archives of neurology 2004;61(12):1920-5.
-
2004: Uitti Ryan J; Calne Donald B; Dickson Dennis W; Wszolek Zbigniew K
Is the neuropathological 'gold standard' diagnosis dead? Implications of clinicopathological findings in an autosomal dominant neurodegenerative disorder.
Parkinsonism & related disorders 2004;10(8):461-3.
-
2004: de la Fuente-Fernández Raúl; Sossi Vesna; Huang Zhigao; Furtado Sarah; Lu Jian-Qiang; Calne Donald B; Ruth Thomas J; Stoessl A Jon
Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias.
Brain : a journal of neurology 2004;127(Pt 12):2747-54.
-
2004: Zimprich Alexander; Biskup Saskia; Leitner Petra; Lichtner Peter; Farrer Matthew; Lincoln Sarah; Kachergus Jennifer; Hulihan Mary; Uitti Ryan J; Calne Donald B; Stoessl A Jon; Pfeiffer Ronald F; Patenge Nadja; Carbajal Iria Carballo; Vieregge Peter; Asmus Friedrich; Müller-Myhsok Bertram; Dickson Dennis W; Meitinger Thomas; Strom Tim M; Wszolek Zbigniew K; Gasser Thomas
Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology.
Neuron 2004;44(4):601-7.
-
2004: Adams J R; Troiano A R; Calne D B
Functional imaging in Tourette's syndrome.
Journal of neural transmission (Vienna, Austria : 1996) 2004;111(10-11):1495-506.
-
2004: Riederer P F; Hirsch E; Youdim M B H; Calne D B
A tribute for Prof. Dr. Melvin D. Yahr, M.D. (1917-2004).
Journal of neural transmission (Vienna, Austria : 1996) 2004;111(10-11):1205-8.
-
2004: Kumar Ajit; Calne Susan M; Schulzer Michael; Mak Edwin; Wszolek Zbigniew; Van Netten Chris; Tsui Joseph K C; Stoessl A Jon; Calne Donald B
Clustering of Parkinson disease: shared cause or coincidence?
Archives of neurology 2004;61(7):1057-60.
-
2004: Calne Donald B; Mizuno Yoshikuni
The neuromythology of Parkinson's Disease.
Parkinsonism & related disorders 2004;10(5):319-22.
-
2004: Furtado Sarah; Payami Haydeh; Lockhart Paul J; Hanson Melissa; Nutt John G; Singleton Andrew A; Singleton Amanda; Bower Jamel; Utti Ryan J; Bird Thomas D; de la Fuente-Fernandez Raul; Tsuboi Yoshio; Klimek Mary L; Suchowersky Oksana; Hardy John; Calne Donald B; Wszolek Zbigniew K; Farrer Matthew; Gwinn-Hardy Katrina; Stoessl A Jon
Profile of families with parkinsonism-predominant spinocerebellar ataxia type 2 (SCA2).
Movement disorders : official journal of the Movement Disorder Society 2004;19(6):622-9.
-
2004: Wszolek Z K; Pfeiffer R F; Tsuboi Y; Uitti R J; McComb R D; Stoessl A J; Strongosky A J; Zimprich A; Müller-Myhsok B; Farrer M J; Gasser T; Calne D B; Dickson D W
Autosomal dominant parkinsonism associated with variable synuclein and tau pathology.
Neurology 2004;62(9):1619-22.
-
2004: de la Fuente-Fernández Raúl; Schulzer Michael; Mak Edwin; Calne Donald B; Stoessl A Jon
Presynaptic mechanisms of motor fluctuations in Parkinson's disease: a probabilistic model.
Brain : a journal of neurology 2004;127(Pt 4):888-99.
-
2004: Zimprich Alexander; Müller-Myhsok Bertram; Farrer Matthew; Leitner Petra; Sharma Manu; Hulihan Mary; Lockhart Paul; Strongosky Audrey; Kachergus Jennifer; Calne Donald B; Stoessl Jon; Uitti Ryan J; Pfeiffer Ronald F; Trenkwalder Claudia; Homann Nikolaus; Ott Erwin; Wenzel Karoline; Asmus Friedrich; Hardy John; Wszolek Zbigniew; Gasser Thomas
The PARK8 locus in autosomal dominant parkinsonism: confirmation of linkage and further delineation of the disease-containing interval.
American journal of human genetics 2004;74(1):11-9.
-
2003: Chen Xianwen; Liu Weiguo; Guoyuan Yang; Liu Zhenguo; Smith Stuart; Calne Donald B; Chen Shengdi
Protective effects of intracerebral adenoviral-mediated GDNF gene transfer in a rat model of Parkinson's disease.
Parkinsonism & related disorders 2003;10(1):1-7.
-
2003: Clewell Harvey J; Lawrence Gregory A; Calne Donald B; Crump Kenny S
Determination of an occupational exposure guideline for manganese using the benchmark method.
Risk analysis : an official publication of the Society for Risk Analysis 2003;23(5):1031-46.
-
2003: De La Fuente-Fernández Raúl; Furtado Sarah; Guttman Mark; Furukawa Yoshiaki; Lee Chong S; Calne Donald B; Ruth Thomas J; Stoessl A Jon
VMAT2 binding is elevated in dopa-responsive dystonia: visualizing empty vesicles by PET.
Synapse (New York, N.Y.) 2003;49(1):20-8.
-
2003: Kaur Harrup; Westerberg Brian D; Mallinson Art; Calne Donald
Progressive supranuclear palsy as a cause of balance disorders.
The Journal of otolaryngology 2003;32(2):114-7.
-
2003: McDonnell G V; Cabrera-Gomez J; Calne D B; Li D K B; Oger J
Clinical presentation of primary progressive multiple sclerosis 10 years after the incidental finding of typical magnetic resonance imaging brain lesions: the subclinical stage of primary progressive multiple sclerosis may last 10 years.
Multiple sclerosis (Houndmills, Basingstoke, England) 2003;9(2):204-9.
-
2003: Carr J; de la Fuente-Fernández R; Schulzer M; Mak E; Calne S M; Calne D B
Familial and sporadic Parkinson's disease usually display the same clinical features.
Parkinsonism & related disorders 2003;9(4):201-4.
-
2003: De La Fuente-Fernández Raúl; Lim Andrew S; Sossi Vesna; Adam Michael J; Ruth Thomas J; Calne Donald B; Stoessl A Jon; Lee Chong S
Age and severity of nigrostriatal damage at onset of Parkinson's disease.
Synapse (New York, N.Y.) 2003;47(2):152-8.
-
2003: Calne Donald B
Parkinson's disease over the last 100 years.
Advances in neurology 2003;91():1-8.
-
2002: Furtado S; Farrer M; Tsuboi Y; Klimek M L; de la Fuente-Fernández R; Hussey J; Lockhart P; Calne D B; Suchowersky O; Stoessl A J; Wszolek Z K
SCA-2 presenting as parkinsonism in an Alberta family: clinical, genetic, and PET findings.
Neurology 2002;59(10):1625-7.
-
2002: de la Fuente-Fernández Raúl; Phillips Anthony G; Zamburlini Mariangela; Sossi Vesna; Calne Donald B; Ruth Thomas J; Stoessl A Jon
Dopamine release in human ventral striatum and expectation of reward.
Behavioural brain research 2002;136(2):359-63.
-
2002: Pal Pramod K; Leung Joanne; Hedrich Katya; Samii Ali; Lieberman Abraham; Nausieda Paul A; Calne Donald B; Breakefield Xandra O; Klein Christine; Stoessl A Jon
[18F]-Dopa positron emission tomography imaging in early-stage, non-parkin juvenile parkinsonism.
Movement disorders : official journal of the Movement Disorder Society 2002;17(4):789-94.
-
2002: Calne Donald B
Synthetic dopamine agonists.
Expert opinion on pharmacotherapy 2002;3(4):363-4.
-
2002: de la Fuente-Fernández Raúl; Calne Donald B
Evidence for environmental causation of Parkinson's disease.
Parkinsonism & related disorders 2002;8(4):235-41.
-
2001: de La Fuente-Fernández R; Lim A S; Sossi V; Holden J E; Calne D B; Ruth T J; Stoessl A J
Apomorphine-induced changes in synaptic dopamine levels: positron emission tomography evidence for presynaptic inhibition.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2001;21(10):1151-9.
-
2001: Pal P K; Wszolek Z K; Uitti R; Markopoulou K; Calne S M; Stoessl A J; Calne D B
Positron emission tomography of dopamine pathways in familial Parkinsonian syndromes.
Parkinsonism & related disorders 2001;8(1):51-6.
-
2001: Hwang W J; Calne D B; Tsui J K; de la Fuente-Fernández R
The long-term response to levodopa in dopa-responsive dystonia.
Parkinsonism & related disorders 2001;8(1):1-5.
-
2001: de la Fuente-Fernández R; Ruth T J; Sossi V; Schulzer M; Calne D B; Stoessl A J
Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease.
Science (New York, N.Y.) 2001;293(5532):1164-6.
-
2001: Hutton J T; Metman L V; Chase T N; Juncos J L; Koller W C; Pahwa R; LeWitt P A; Samii A; Tsui J K; Calne D B; Waters C H; Calabrese V P; Bennett J P; Barrett R; Morris J L
Transdermal dopaminergic D(2) receptor agonist therapy in Parkinson's disease with N-0923 TDS: a double-blind, placebo-controlled study.
Movement disorders : official journal of the Movement Disorder Society 2001;16(3):459-63.
-
2001: de la Fuente-Fernández R; Calne D B
Familial aggregation of Parkinson's disease.
The New England journal of medicine 2001;344(15):1168.
-
2001: de la Fuente-Fernández R; Lu J Q; Sossi V; Jivan S; Schulzer M; Holden J E; Lee C S; Ruth T J; Calne D B; Stoessl A J
Biochemical variations in the synaptic level of dopamine precede motor fluctuations in Parkinson's disease: PET evidence of increased dopamine turnover.
Annals of neurology 2001;49(3):298-303.
-
2000: Pal P K; Samii A; Kishore A; Schulzer M; Mak E; Yardley S; Turnbull I M; Calne D B
Long term outcome of unilateral pallidotomy: follow up of 15 patients for 3 years.
Journal of neurology, neurosurgery, and psychiatry 2000;69(3):337-44.
-
2000: de la Fuente-Fernández R; Kishore A; Calne D B; Ruth T J; Stoessl A J
Nigrostriatal dopamine system and motor lateralization.
Behavioural brain research 2000;112(1-2):63-8.
-
2000: Beaman B L; Canfield D; Anderson J; Pate B; Calne D
Site-specific invasion of the basal ganglia by Nocardia asteroides GUH-2.
Medical microbiology and immunology 2000;188(4):161-8.
-
2000: Lee C S; Samii A; Sossi V; Ruth T J; Schulzer M; Holden J E; Wudel J; Pal P K; de la Fuente-Fernandez R; Calne D B; Stoessl A J
In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease.
Annals of neurology 2000;47(4):493-503.
-
2000: Snow B J; Vingerhoets F J; Langston J W; Tetrud J W; Sossi V; Calne D B
Pattern of dopaminergic loss in the striatum of humans with MPTP induced parkinsonism.
Journal of neurology, neurosurgery, and psychiatry 2000;68(3):313-6.
-
2000: Pal P K; Calne D B; Calne S; Tsui J K
Botulinum toxin A as treatment for drooling saliva in PD.
Neurology 2000;54(1):244-7.
-
2000: de la Fuente-Fernández R; Pal P K; Vingerhoets F J; Kishore A; Schulzer M; Mak E K; Ruth T J; Snow B J; Calne D B; Stoessl A J
Evidence for impaired presynaptic dopamine function in parkinsonian patients with motor fluctuations.
Journal of neural transmission (Vienna, Austria : 1996) 2000;107(1):49-57.
-
1999: Samii A; Markopoulou K; Wszolek Z K; Sossi V; Dobko T; Mak E; Calne D B; Stoessl A J
PET studies of parkinsonism associated with mutation in the alpha-synuclein gene.
Neurology 1999;53(9):2097-102.
-
1999: Agid Y; Ahlskog E; Albanese A; Calne D; Chase T; De Yebenes J; Factor S; Fahn S; Gershanik O; Goetz C; Koller W; Kurth M; Lang A; Lees A; Lewitt P; Marsden D; Melamed E; Michel P P; Mizuno Y; Obeso J; Oertel W; Olanow W; Poewe W; Pollak P; Tolosa E
Levodopa in the treatment of Parkinson's disease: a consensus meeting.
Movement disorders : official journal of the Movement Disorder Society 1999;14(6):911-3.
-
1999: Tsui J K; Calne D B; Wang Y; Schulzer M; Marion S A
Occupational risk factors in Parkinson's disease.
Canadian journal of public health. Revue canadienne de santé publique 1999;90(5):334-7.
-
1999: Honey C R; Stoessl A J; Tsui J K; Schulzer M; Calne D B
Unilateral pallidotomy for reduction of parkinsonian pain.
Journal of neurosurgery 1999;91(2):198-201.
-
1999: Pal P K; Samii A; Calne D B
Manganese neurotoxicity: a review of clinical features, imaging and pathology.
Neurotoxicology 1999;20(2-3):227-38.
-
1999: Samii A; Turnbull I M; Kishore A; Schulzer M; Mak E; Yardley S; Calne D B
Reassessment of unilateral pallidotomy in Parkinson's disease. A 2-year follow-up study.
Brain : a journal of neurology 1999;122 ( Pt 3)():417-25.
-
1999: Chan G L; Holden J E; Stoessl A J; Samii A; Doudet D J; Dobko T; Morrison K S; Adam M; Schulzer M; Calne D B; Ruth T J
Reproducibility studies with 11C-DTBZ, a monoamine vesicular transporter inhibitor in healthy human subjects.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1999;40(2):283-9.
-
1999: Calne D B
Differentiation of dopamine agonists and their role in the treatment of Parkinson's disease.
Journal of neural transmission. Supplementum 1999;56():185-92.
-
1998: Perl D P; Olanow C W; Calne D
Alzheimer's disease and Parkinson's disease: distinct entities or extremes of a spectrum of neurodegeneration?
Annals of neurology 1998;44(3 Suppl 1):S19-31.
-
1998: Wang Y; Chan G L; Holden J E; Dobko T; Mak E; Schulzer M; Huser J M; Snow B J; Ruth T J; Calne D B; Stoessl A J
Age-dependent decline of dopamine D1 receptors in human brain: a PET study.
Synapse (New York, N.Y.) 1998;30(1):56-61.
-
1998: de la Fuente-Fernandez R; Schulzer M; Mak E; Kishore A; Calne D B
The role of the Lewy body in idiopathic Parkinsonism.
Parkinsonism & related disorders 1998;4(2):73-7.
-
1998: Muenter M D; Forno L S; Hornykiewicz O; Kish S J; Maraganore D M; Caselli R J; Okazaki H; Howard F M; Snow B J; Calne D B
Hereditary form of parkinsonism--dementia.
Annals of neurology 1998;43(6):768-81.
-
1998: Chan G L; Holden J E; Stoessl A J; Doudet D J; Wang Y; Dobko T; Morrison K S; Huser J M; English C; Legg B; Schulzer M; Calne D B; Ruth T J
Reproducibility of the distribution of carbon-11-SCH 23390, a dopamine D1 receptor tracer, in normal subjects.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1998;39(5):792-7.
-
1998: Kishore A; Nygaard T G; de la Fuente-Fernandez R; Naini A B; Schulzer M; Mak E; Ruth T J; Calne D B; Snow B J; Stoessl A J
Striatal D2 receptors in symptomatic and asymptomatic carriers of dopa-responsive dystonia measured with [11C]-raclopride and positron-emission tomography.
Neurology 1998;50(4):1028-32.
-
1998: Huang C C; Chu N S; Lu C S; Chen R S; Calne D B
Long-term progression in chronic manganism: ten years of follow-up.
Neurology 1998;50(3):698-700.
-
1998: Gasser T; Müller-Myhsok B; Wszolek Z K; Oehlmann R; Calne D B; Bonifati V; Bereznai B; Fabrizio E; Vieregge P; Horstmann R D
A susceptibility locus for Parkinson's disease maps to chromosome 2p13.
Nature genetics 1998;18(3):262-5.
-
1997: Wszolek Z K; Vieregge P; Uitti R J; Gasser T; Yasuhara O; McGeer P; Berry K; Calne D B; Vingerhoets F J; Klein C; Pfeiffer R F
German-Canadian family (family A) with parkinsonism, amyotrophy, and dementia - Longitudinal observations.
Parkinsonism & related disorders 1997;3(3):125-39.
-
1997: Shinotoh H; Thiessen B; Snow B J; Hashimoto S; MacLeod P; Silveira I; Rouleau G A; Schulzer M; Calne D B
Fluorodopa and raclopride PET analysis of patients with Machado-Joseph disease.
Neurology 1997;49(4):1133-6.
-
1997: Huang C C; Chu N S; Lu C S; Calne D B
Cock gait in manganese intoxication.
Movement disorders : official journal of the Movement Disorder Society 1997;12(5):807-8.
-
1997: Doudet D J; Chan G L; Holden J E; Pate B D; Morrison K S; Calne D B; Ruth T J
Effects of monoamine oxidase and catechol-O-methyltransferase inhibition on dopamine turnover: a PET study with 6-[18F]L-DOPA.
European journal of pharmacology 1997;334(1):31-8.
-
1997: Kishore A; Turnbull I M; Snow B J; de la Fuente-Fernandez R; Schulzer M; Mak E; Yardley S; Calne D B
Efficacy, stability and predictors of outcome of pallidotomy for Parkinson's disease. Six-month follow-up with additional 1-year observations.
Brain : a journal of neurology 1997;120 ( Pt 5)():729-37.
-
1997: Uitti R J; Shinotoh H; Hayward M; Schulzer M; Mak E; Calne D B
"Familial Parkinson's disease"--a case-control study of families.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1997;24(2):127-32.
-
1997: Shinotoh H; Vingerhoets F J; Lee C S; Uitti R J; Schulzer M; Calne D B; Tsui J
Lamotrigine trial in idiopathic parkinsonism: a double-blind, placebo-controlled, crossover study.
Neurology 1997;48(5):1282-5.
-
1997: Shinotoh H; Snow B J; Chu N S; Huang C C; Lu C S; Lee C; Takahashi H; Calne D B
Presynaptic and postsynaptic striatal dopaminergic function in patients with manganese intoxication: a positron emission tomography study.
Neurology 1997;48(4):1053-6.
-
1997: Wang Y; Turnbull I; Calne S; Stoessl A J; Calne D B
Pallidotomy for tardive dyskinesia.
Lancet 1997;349(9054):777-8.
-
1997: Vingerhoets F J; Schulzer M; Calne D B; Snow B J
Which clinical sign of Parkinson's disease best reflects the nigrostriatal lesion?
Annals of neurology 1997;41(1):58-64.
-
1997: Calne D B; de la Fuente-Fernández R; Kishore A
Contributions of positron emission tomography to elucidating the pathogenesis of idiopathic parkinsonism and dopa responsive dystonia.
Journal of neural transmission. Supplementum 1997;50():47-52.
-
1996: Kishore A; Wszolek Z K; Snow B J; de la Fuente-Fernandez R; Arwert F; Wijker M; Schulzer M; Calne D B; Vingerhoets F J
Presynaptic nigrostriatal function in genetically tested asymptomatic relatives from the pallido-ponto-nigral degeneration family.
Neurology 1996;47(6):1588-90.
-
1996: Litvan I; Agid Y; Calne D; Campbell G; Dubois B; Duvoisin R C; Goetz C G; Golbe L I; Grafman J; Growdon J H; Hallett M; Jankovic J; Quinn N P; Tolosa E; Zee D S
Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop.
Neurology 1996;47(1):1-9.
-
1996: Olanow C W; Good P F; Shinotoh H; Hewitt K A; Vingerhoets F; Snow B J; Beal M F; Calne D B; Perl D P
Manganese intoxication in the rhesus monkey: a clinical, imaging, pathologic, and biochemical study.
Neurology 1996;46(2):492-8.
-
1996: Chu N S; Huang C C; Calne D B
Sympathetic skin response and RR interval variation in manganism and a comparison with Parkinson's disease.
Parkinsonism & related disorders 1996;2(1):23-8.
-
1996: Gasser T; Wszolek Z; Supala A; Trofatter J; Ozelius L; Uitti R J; Pfeiffer R F; Gusella J; Calne D; Breakefield X O
Genetic linkage studies in autosomal dominantly inherited L-DOPA responsive parkinsonism. Evaluation of candidate genes.
Advances in neurology 1996;69():87-95.
-
1995: Calne D B
Selegiline in Parkinson's disease.
BMJ (Clinical research ed.) 1995;311(7020):1583-4.
-
1995: Lin S K; Lu C S; Vingerhoets F; Snow B J; Wai Y Y; Chu N S; Calne D B
Isolated involvement of substantia nigra in acute transient parkinsonism: MRI and PET observations.
Parkinsonism & related disorders 1995;1(2):67-72.
-
1995: Duarte J; Clavería L E; de Pedro-Cuesta J; Sempere A P; Coria F; Calne D B
Screening Parkinson's disease: a validated questionnaire of high specificity and sensitivity.
Movement disorders : official journal of the Movement Disorder Society 1995;10(5):643-9.
-
1995: Shinotoh H; Calne D B
The use of PET in Parkinson's disease.
Brain and cognition 1995;28(3):297-310.
-
1995: Uitti R J; Berry K; Yasuhara O; Eisen A; Feldman H; McGeer P L; Calne D B
Neurodegenerative 'overlap' syndrome: Clinical and pathological features of Parkinson's disease, motor neuron disease, and Alzheimer's disease.
Parkinsonism & related disorders 1995;1(1):21-34.
-
1995: Calne D B
Editorial.
Parkinsonism & related disorders 1995;1(1):1.
-
1995: Shinotoh H; Snow B J; Hewitt K A; Pate B D; Doudet D; Nugent R; Perl D P; Olanow W; Calne D B
MRI and PET studies of manganese-intoxicated monkeys.
Neurology 1995;45(6):1199-204.
-
1995: Wszolek Z K; Pfeiffer B; Fulgham J R; Parisi J E; Thompson B M; Uitti R J; Calne D B; Pfeiffer R F
Western Nebraska family (family D) with autosomal dominant parkinsonism.
Neurology 1995;45(3 Pt 1):502-5.
-
1995: Lee C S; Schulzer M; Mak E; Hammerstad J P; Calne S; Calne D B
Patterns of asymmetry do not change over the course of idiopathic parkinsonism: implications for pathogenesis.
Neurology 1995;45(3 Pt 1):435-9.
-
1995: Calne D B
Diagnosis and treatment of Parkinson's disease.
Hospital practice (Office ed.) 1995;30(1):83-6, 89.
-
1994: Vingerhoets F J; Snow B J; Tetrud J W; Langston J W; Schulzer M; Calne D B
Positron emission tomographic evidence for progression of human MPTP-induced dopaminergic lesions.
Annals of neurology 1994;36(5):765-70.
-
1994: Vingerhoets F J; Snow B J; Lee C S; Schulzer M; Mak E; Calne D B
Longitudinal fluorodopa positron emission tomographic studies of the evolution of idiopathic parkinsonism.
Annals of neurology 1994;36(5):759-64.
-
1994: Shinotoh H; Calne D B; Snow B; Hayward M; Kremer B; Theilmann J; Hayden M R
Normal CAG repeat length in the Huntington's disease gene in senile chorea.
Neurology 1994;44(11):2183-4.
-
1994: Cordes M; Snow B J; Cooper S; Schulzer M; Pate B D; Ruth T J; Calne D B
Age-dependent decline of nigrostriatal dopaminergic function: a positron emission tomographic study of grandparents and their grandchildren.
Annals of neurology 1994;36(4):667-70.
-
1994: Lu C S; Huang C C; Chu N S; Calne D B
Levodopa failure in chronic manganism.
Neurology 1994;44(9):1600-2.
-
1994: Calne D B; Chu N S; Huang C C; Lu C S; Olanow W
Manganism and idiopathic parkinsonism: similarities and differences.
Neurology 1994;44(9):1583-6.
-
1994: Gasser T; Wszolek Z K; Trofatter J; Ozelius L; Uitti R J; Lee C S; Gusella J; Pfeiffer R F; Calne D B; Breakefield X O
Genetic linkage studies in autosomal dominant parkinsonism: evaluation of seven candidate genes.
Annals of neurology 1994;36(3):387-96.
-
1994: Calne D B
Initiating treatment for idiopathic parkinsonism.
Neurology 1994;44(7 Suppl 6):S19-22.
-
1994: Schulzer M; Lee C S; Mak E K; Vingerhoets F J; Calne D B
A mathematical model of pathogenesis in idiopathic parkinsonism.
Brain : a journal of neurology 1994;117 ( Pt 3)():509-16.
-
1994: Lee C S; Schulzer M; Mak E K; Snow B J; Tsui J K; Calne S; Hammerstad J; Calne D B
Clinical observations on the rate of progression of idiopathic parkinsonism.
Brain : a journal of neurology 1994;117 ( Pt 3)():501-7.
-
1994: Uitti R J; Snow B J; Shinotoh H; Vingerhoets F J; Hayward M; Hashimoto S; Richmond J; Markey S P; Markey C J; Calne D B
Parkinsonism induced by solvent abuse.
Annals of neurology 1994;35(5):616-9.
-
1994: Calne D B
Dopa-responsive dystonia.
Annals of neurology 1994;35(4):381-2.
-
1994: Takahashi H; Levine R A; Galloway M P; Snow B J; Calne D B; Nygaard T G
Biochemical and fluorodopa positron emission tomographic findings in an asymptomatic carrier of the gene for dopa-responsive dystonia.
Annals of neurology 1994;35(3):354-6.
-
1994: Calne D B; Duvoisin R C; Koller W C
Individualizing therapy in patients with disabling Parkinson's disease symptoms.
Neurology 1994;44(3 Suppl 1):S8-11.
-
1994: Calne D B
Is idiopathic parkinsonism the consequence of an event or a process?
Neurology 1994;44(1):5-10.
-
1994: Vingerhoets F J; Snow B J; Schulzer M; Morrison S; Ruth T J; Holden J E; Cooper S; Calne D B
Reproducibility of fluorine-18-6-fluorodopa positron emission tomography in normal human subjects.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1994;35(1):18-24.
-
1994: Hertzman C; Wiens M; Snow B; Kelly S; Calne D
A case-control study of Parkinson's disease in a horticultural region of British Columbia.
Movement disorders : official journal of the Movement Disorder Society 1994;9(1):69-75.
-
1994: Calne D B
Early idiopathic parkinsonism: initiation and optimization of treatment.
Clinical neuropharmacology 1994;17 Suppl 2():S14-8.
-
1994: Vingerhoets F J; Uitti R J; Calne D B
Deprenyl and the issue of neuroprotection.
European neurology 1994;34(1):1-3.
-
1994: Hammerstad J P; Elliott K; Mak E; Schulzer M; Calne S; Calne D B
Tendon jerks in Parkinson's disease.
Journal of neural transmission. Parkinson's disease and dementia section 1994;8(1-2):123-30.
-
1993: Snow B J; Nygaard T G; Takahashi H; Calne D B
Positron emission tomographic studies of dopa-responsive dystonia and early-onset idiopathic parkinsonism.
Annals of neurology 1993;34(5):733-8.
-
1993: Schulzer M; Calne D B; Snow B; Mak E
A scoring error in the Mini-Mental State test.
Canadian journal of psychiatry. Revue canadienne de psychiatrie 1993;38(9):603-5.
-
1993: Hammerstad J P; Pate B D; Hewitt K A; Chan G L; Ruth T J; Calne D B
The transport of L-6-fluorodopa and its metabolites from blood to cerebrospinal fluid and brain.
Annals of neurology 1993;34(4):603-8.
-
1993: Takahashi H; Snow B J; Bhatt M H; Peppard R; Eisen A; Calne D B
Evidence for a dopaminergic deficit in sporadic amyotrophic lateral sclerosis on positron emission scanning.
Lancet 1993;342(8878):1016-8.
-
1993: Glosser G; Wolfe N; Albert M L; Lavine L; Steele J C; Calne D B; Schoenberg B S
Cross-cultural cognitive examination: validation of a dementia screening instrument for neuroepidemiological research.
Journal of the American Geriatrics Society 1993;41(9):931-9.
-
1993: Calne D B
Treatment of Parkinson's disease.
The New England journal of medicine 1993;329(14):1021-7.
-
1993: Pate B D; Kawamata T; Yamada T; McGeer E G; Hewitt K A; Snow B J; Ruth T J; Calne D B
Correlation of striatal fluorodopa uptake in the MPTP monkey with dopaminergic indices.
Annals of neurology 1993;34(3):331-8.
-
1993: Snow B J; Tooyama I; McGeer E G; Yamada T; Calne D B; Takahashi H; Kimura H
Human positron emission tomographic [18F]fluorodopa studies correlate with dopamine cell counts and levels.
Annals of neurology 1993;34(3):324-30.
-
1993: Waters C H; Takahashi H; Wilhelmsen K C; Shubin R; Snow B J; Nygaard T G; Moskowitz C B; Fahn S; Calne D B
Phenotypic expression of X-linked dystonia-parkinsonism (lubag) in two women.
Neurology 1993;43(8):1555-8.
-
1993: Huang C C; Lu C S; Chu N S; Hochberg F; Lilienfeld D; Olanow W; Calne D B
Progression after chronic manganese exposure.
Neurology 1993;43(8):1479-83.
-
1993: Wszolek Z K; Cordes M; Calne D B; Münter M D; Cordes I; Pfeifer R F
[Hereditary Parkinson disease: report of 3 families with dominant autosomal inheritance]
Der Nervenarzt 1993;64(5):331-5.
-
1993: Tsui J K; Bhatt M; Calne S; Calne D B
Botulinum toxin in the treatment of writer's cramp: a double-blind study.
Neurology 1993;43(1):183-5.
-
1993: Okada A; Nakamura K; Snow B J; Bhatt M H; Nomoto M; Osame M; Calne D B
PET scan study on the dopaminergic system in a Japanese patient with hereditary progressive dystonia (Segawa's disease). Case report.
Advances in neurology 1993;60():591-4.
-
1993: Takahashi H; Snow B J; Nygaard T G; Calne D B
Clinical heterogeneity of dopa-responsive dystonia: PET observations.
Advances in neurology 1993;60():586-90.
-
1993: Calne D B; Snow B J
PET imaging in Parkinsonism.
Advances in neurology 1993;60():484-7.
-
1993: Cordes M; Snow B J; Morrison S; Sossi V; Ruth T J; Calne D B
Parametric imaging of the rate constant Ki using [18Fluoro]-L-dopa positron emission tomography in progressive supranuclear palsy.
Neuroradiology 1993;35(6):404-9.
-
1993: Uitti R J; Calne D B
Pathogenesis of idiopathic parkinsonism.
European neurology 1993;33 Suppl 1():6-23.
-
1993: Yamada T; Calne D B; Akiyama H; McGeer E G; McGeer P L
Further observations on Tau-positive glia in the brains with progressive supranuclear palsy.
Acta neuropathologica 1993;85(3):308-15.
-
1992: Calne D B
The free radical hypothesis in idiopathic parkinsonism: evidence against it.
Annals of neurology 1992;32(6):799-803.
-
1992: Schulzer M; Mak E; Calne D B
The antiparkinson efficacy of deprenyl derives from transient improvement that is likely to be symptomatic.
Annals of neurology 1992;32(6):795-8.
-
1992: Peppard R F; Martin W R; Carr G D; Grochowski E; Schulzer M; Guttman M; McGeer P L; Phillips A G; Tsui J K; Calne D B
Cerebral glucose metabolism in Parkinson's disease with and without dementia.
Archives of neurology 1992;49(12):1262-8.
-
1992: Nygaard T G; Takahashi H; Heiman G A; Snow B J; Fahn S; Calne D B
Long-term treatment response and fluorodopa positron emission tomographic scanning of parkinsonism in a family with dopa-responsive dystonia.
Annals of neurology 1992;32(5):603-8.
-
1992: Wszolek Z K; Pfeiffer R F; Bhatt M H; Schelper R L; Cordes M; Snow B J; Rodnitzky R L; Wolters E C; Arwert F; Calne D B
Rapidly progressive autosomal dominant parkinsonism and dementia with pallido-ponto-nigral degeneration.
Annals of neurology 1992;32(3):312-20.
-
1992: Calne D B; Calne R
Citation of original research.
Lancet 1992;340(8813):244.
-
1992: Calne D B; Hochberg F H; Snow B J; Nygaard T
Theories of neurodegeneration.
Annals of the New York Academy of Sciences 1992;648():1-5.
-
1992: Manyam B V; Bhatt M H; Moore W D; Devleschoward A B; Anderson D R; Calne D B
Bilateral striopallidodentate calcinosis: cerebrospinal fluid, imaging, and electrophysiological studies.
Annals of neurology 1992;31(4):379-84.
-
1992: Olanow C W; Calne D
Does selegiline monotherapy in Parkinson's disease act by symptomatic or protective mechanisms?
Neurology 1992;42(4 Suppl 4):13-26; discussion 41-8.
-
1992: Cordes M; Snow B J; Takahashi H; Schofield P; Cooper S; Sossi V; Morrison S; Calne D B
[L-18F-dopa-PET in Parkinson-plus syndromes for the detection of a disordered presynaptic dopaminergic function]
Nuklearmedizin. Nuclear medicine 1992;31(2):43-7.
-
1992: Calne D B
The nature of Parkinson's disease.
Neurochemistry international 1992;20 Suppl():1S-3S.
-
1992: Eisen A; Calne D
Amyotrophic lateral sclerosis, Parkinson's disease and Alzheimer's disease: phylogenetic disorders of the human neocortex sharing many characteristics.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1992;19(1 Suppl):117-23.
-
1992: Calne D B; Snow B J; Lee C
Criteria for diagnosing Parkinson's disease.
Annals of neurology 1992;32 Suppl():S125-7.
-
1991: Bhatt M H; Keenan S P; Fleetham J A; Calne D B
Pleuropulmonary disease associated with dopamine agonist therapy.
Annals of neurology 1991;30(4):613-6.
-
1991: Calne D B; Eisen A; Meneilly G
Normal aging of the nervous system.
Annals of neurology 1991;30(2):206-7.
-
1991: Pate B D; Snow B J; Hewitt K A; Morrison K S; Ruth T J; Calne D B
The reproducibility of striatal uptake data obtained with positron emission tomography and fluorine-18-L-6-fluorodopa tracer in non-human primates.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1991;32(6):1246-51.
-
1991: Bhatt M H; Snow B J; Martin W R; Pate B D; Ruth T J; Calne D B
Positron emission tomography suggests that the rate of progression of idiopathic parkinsonism is slow.
Annals of neurology 1991;29(6):673-7.
-
1991: Eisen A; Siejka S; Schulzer M; Calne D
Age-dependent decline in motor evoked potential (MEP) amplitude: with a comment on changes in Parkinson's disease.
Electroencephalography and clinical neurophysiology 1991;81(3):209-15.
-
1991: Calne D B; Zigmond M J
Compensatory mechanisms in degenerative neurologic diseases. Insights from parkinsonism.
Archives of neurology 1991;48(4):361-3.
-
1991: Bhatt M H; Snow B J; Martin W R; Peppard R; Calne D B
Positron emission tomography in progressive supranuclear palsy.
Archives of neurology 1991;48(4):389-91.
-
1991: Rajput A H; Calne D; Lang A E
National conference on Parkinson's disease.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1991;18(1):87-92.
-
1991: Snow B J; Bhatt M; Martin W R; Li D; Calne D B
The nigrostriatal dopaminergic pathway in Wilson's disease studied with positron emission tomography.
Journal of neurology, neurosurgery, and psychiatry 1991;54(1):12-7.
-
1991: Lavine L; Steele J C; Wolfe N; Calne D B; O'Brien P C; Williams D B; Kurland L T; Schoenberg B S
Amyotrophic lateral sclerosis/parkinsonism-dementia complex in southern Guam: is it disappearing?
Advances in neurology 1991;56():271-85.
-
1991: Calne D B
Neurotoxins and degeneration in the central nervous system.
Neurotoxicology 1991;12(3):335-9.
-
1990: Peppard R F; Martin W R; Clark C M; Carr G D; McGeer P L; Calne D B
Cortical glucose metabolism in Parkinson's and Alzheimer's disease.
Journal of neuroscience research 1990;27(4):561-8.
-
1990: Snow B J; Tsui J K; Bhatt M H; Varelas M; Hashimoto S A; Calne D B
Treatment of spasticity with botulinum toxin: a double-blind study.
Annals of neurology 1990;28(4):512-5.
-
1990: Snow B J; Peppard R F; Guttman M; Okada J; Martin W R; Steele J; Eisen A; Carr G; Schoenberg B; Calne D
Positron emission tomographic scanning demonstrates a presynaptic dopaminergic lesion in Lytico-Bodig. The amyotrophic lateral sclerosis-parkinsonism-dementia complex of Guam.
Archives of neurology 1990;47(8):870-4.
-
1990: Peppard R F; Lu C S; Chu N S; Teal P; Martin W R; Calne D B
Parkinsonism with neuroacanthocytosis.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1990;17(3):298-301.
-
1990: Bhatt M H; Snow B J; Martin W R; Cooper S; Calne D B
Positron emission tomography in Shy-Drager syndrome.
Annals of neurology 1990;28(1):101-3.
-
1990: Tsui J K; Peppard R F; Petruk K C; Allen G; Burns R S; Calne D B
Decreased efficacy of levodopa with carbidopa in parkinsonian patients after adrenal-to-caudate implants.
Neurology 1990;40(5):845-6.
-
1990: Wolters E C; Hurwitz T A; Mak E; Teal P; Peppard F R; Remick R; Calne S; Calne D B
Clozapine in the treatment of parkinsonian patients with dopaminomimetic psychosis.
Neurology 1990;40(5):832-4.
-
1990: Guttman M; Fibiger H C; Jakubovic A; Calne D B
Intracarotid 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration: biochemical and behavioral observations in a primate model of hemiparkinsonism.
Journal of neurochemistry 1990;54(4):1329-34.
-
1990: McGeer E G; Peppard R P; McGeer P L; Tuokko H; Crockett D; Parks R; Akiyama H; Calne D B; Beattie B L; Harrop R
18Fluorodeoxyglucose positron emission tomography studies in presumed Alzheimer cases, including 13 serial scans.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1990;17(1):1-11.
-
1990: Hertzman C; Wiens M; Bowering D; Snow B; Calne D
Parkinson's disease: a case-control study of occupational and environmental risk factors.
American journal of industrial medicine 1990;17(3):349-55.
-
1990: Bhatt M; Wolters E; Tsui J; Snow B J; Calne D B
A case of rabies in North America.
Movement disorders : official journal of the Movement Disorder Society 1990;5(1):40-3.
-
1990: Bhatt M; Snow B; Varelas M; Calne D
Palatal myoclonus: treatment with 5-hydroxytryptophan and carbidopa.
Movement disorders : official journal of the Movement Disorder Society 1990;5(4):339-40.
-
1990: Calne D B; Eisen A
Parkinson's disease, motoneuron disease and Alzheimer's disease: origins and interrelationship.
Advances in neurology 1990;53():355-60.
-
1990: Petruk K C; Wilson A F; Schindel D R; Witt N J; McLean D R; McFarland P A; Johnston R G; McPhee M S; Martin W R; Calne D B
Treatment of refractory Parkinson's disease with adrenal medullary autografts utilizing two-stage surgery.
Progress in brain research 1990;82():671-6.
-
1989: Cox T A; McDarby J V; Lavine L; Steele J C; Calne D B
A retinopathy on Guam with high prevalence in Lytico-Bodig.
Ophthalmology 1989;96(12):1731-5.
-
1989: Yong V W; Guttman M; Kim S U; Calne D B; Turnbull I; Watabe K; Tomlinson R W
Transplantation of human sympathetic neurons and adrenal chromaffin cells into parkinsonian monkeys: no reversal of clinical symptoms.
Journal of the neurological sciences 1989;94(1-3):51-67.
-
1989: Calne D B; Eisen A
The relationship between Alzheimer's disease, Parkinson's disease and motor neuron disease.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1989;16(4 Suppl):547-50.
-
1989: Wolters E C; Huang C C; Clark C; Peppard R F; Okada J; Chu N S; Adam M J; Ruth T J; Li D; Calne D B
Positron emission tomography in manganese intoxication.
Annals of neurology 1989;26(5):647-51.
-
1989: Huang C C; Chu N S; Lu C S; Wang J D; Tsai J L; Tzeng J L; Wolters E C; Calne D B
Chronic manganese intoxication.
Archives of neurology 1989;46(10):1104-6.
-
1989: Martin W R; Palmer M R; Patlak C S; Calne D B
Nigrostriatal function in humans studied with positron emission tomography.
Annals of neurology 1989;26(4):535-42.
-
1989: Snow B; Wiens M; Hertzman C; Calne D
A community survey of Parkinson's disease.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 1989;141(5):418-22.
-
1989: Guttman M; Burns R S; Martin W R; Peppard R F; Adam M J; Ruth T J; Allen G; Parker R A; Tulipan N B; Calne D B
PET studies of parkinsonian patients treated with autologous adrenal implants.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1989;16(3):305-9.
-
1989: Tsui J K; Wolters E C; Peppard R F; Calne D B
A double-blind, placebo-controlled, dose-ranging study to investigate the safety and efficacy of CY 208-243 in patients with Parkinson's disease.
Neurology 1989;39(6):856-8.
-
1989: Calne D B
Is "Parkinson's disease" one disease?
Journal of neurology, neurosurgery, and psychiatry 1989;Suppl():18-21.
-
1989: Okada J; Peppard R; Calne D B
[Comparison study of positron emission tomography, X-ray CT and MRI in parkinsonism with dementia]
Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica 1989;49(5):643-56.
-
1989: Teräväinen H; Tsui J K; Mak E; Calne D B
Optimal indices for testing parkinsonian rigidity.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1989;16(2):180-3.
-
1989: Wolters E C; Hurwitz T A; Peppard R F; Calne D B
Clozapine: an antipsychotic agent in Parkinson's disease?
Clinical neuropharmacology 1989;12(2):83-90.
-
1989: Tsui J K; Ross S; Poulin K; Douglas J; Postnikoff D; Calne S; Woodward W; Calne D B
The effect of dietary protein on the efficacy of L-dopa: a double-blind study.
Neurology 1989;39(4):549-52.
-
1989: Calne D B; Dubini A; Stern G
Did Leonardo describe Parkinson's disease?
The New England journal of medicine 1989;320(9):594.
-
1989: Wolters E C; Calne D B
Parkinson's disease.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 1989;140(5):507-14.
-
1989: Calne D B
Current concepts on the etiology of Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1989;4 Suppl 1():S11-4.
-
1988: Wolters E C; Kebabian J C; Guttman M; Mak E; Pate B D; Calne D B
A new device for the quantitative assessment of dopaminergic drug effects in unilateral MPTP-lesioned monkeys.
Neuroscience letters 1988;95(1-3):257-61.
-
1988: Lepore F E; Steele J C; Cox T A; Tillson G; Calne D B; Duvoisin R C; Lavine L; McDarby J V
Supranuclear disturbances of ocular motility in Lytico-Bodig.
Neurology 1988;38(12):1849-53.
-
1988: Calne D B; McGeer P L
Tissue transplantation for Parkinson's disease.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1988;15(4):364-5.
-
1988: Calne D B
Parkinson's disease over the last 20 years: a personal view.
Functional neurology 1988;3(4):395-406.
-
1988: Calne D B; Lees A J
Late progression of post-encephalitic Parkinson's syndrome.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1988;15(2):135-8.
-
1988: Hurwitz T A; Calne D B; Waterman K
Treatment of dopaminomimetic psychosis in Parkinson's disease with electroconvulsive therapy.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1988;15(1):32-4.
-
1988: Calne D B; Calne J S
Normality and disease.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1988;15(1):3-4.
-
1988: Calne D B
Options for the etiology of Parkinson's disease: the association with dementia.
The Mount Sinai journal of medicine, New York 1988;55(1):58-61.
-
1988: Tsui J K; Eisen A; Calne D B
Botulinum toxin in spasmodic torticollis.
Advances in neurology 1988;50():593-7.
-
1988: Suchowersky O; Calne D B
Non-dystonic causes of torticollis.
Advances in neurology 1988;50():501-8.
-
1988: Tsui J K; Calne D B
Botulinum toxin in cervical dystonia.
Advances in neurology 1988;49():473-8.
-
1988: Guttman M; Yong V W; Kim S U; Calne D B; Martin W R; Adam M J; Ruth T J
Asymptomatic striatal dopamine depletion: PET scans in unilateral MPTP monkeys.
Synapse (New York, N.Y.) 1988;2(5):469-73.
-
1988: Martin W R; Stoessl A J; Palmer M; Adam M J; Ruth T J; Grierson J R; Pate B D; Calne D B
PET scanning in dystonia.
Advances in neurology 1988;50():223-9.
-
1988: Shale H; Fahn S; Calne D B
Case 1, 1988. Head tilt in a young girl associated with neck pain and limitation of neck movement.
Movement disorders : official journal of the Movement Disorder Society 1988;3(4):347-51.
-
1988: Calne D B; Lang A E
Secondary dystonia.
Advances in neurology 1988;50():9-33.
-
1988: Teräväinen H; Calne S; Burton K; Beckman J; Calne D B
Efficacy of dopamine agonists in dystonia.
Advances in neurology 1988;50():571-8.
-
1987: Tsui J K; Fross R D; Calne S; Calne D B
Local treatment of spasmodic torticollis with botulinum toxin.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1987;14(3 Suppl):533-5.
-
1987: Calne D B; Peppard R F
Aging of the nigrostriatal pathway in humans.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1987;14(3 Suppl):424-7.
-
1987: Calne S; Schoenberg B; Martin W; Uitti R J; Spencer P; Calne D B
Familial Parkinson's disease: possible role of environmental factors.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1987;14(3):303-5.
-
1987: Fross R D; Martin W R; Li D; Stoessl A J; Adam M J; Ruth T J; Pate B D; Burton K; Calne D B
Lesions of the putamen: their relevance to dystonia.
Neurology 1987;37(7):1125-9.
-
1987: Kamo H; McGeer P L; Harrop R; McGeer E G; Calne D B; Martin W R; Pate B D
Positron emission tomography and histopathology in Pick's disease.
Neurology 1987;37(3):439-45.
-
1987: Calne D B; Stoessl A J
Transmitter receptor alterations in Parkinson's disease.
Advances in neurology 1987;45():45-9.
-
1986: Teräväinen H; Forgach L; Hietanen M; Schulzer M; Schoenberg B; Calne D B
The age of onset of Parkinson's disease: etiological implications.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1986;13(4):317-9.
-
1986: Teräväinen H; Hietanen M; Stoessl J; Calne D B
Dementia in movement disorders.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1986;13(4 Suppl):546-58.
-
1986: Calne D B; Eisen A; McGeer E; Spencer P
Alzheimer's disease, Parkinson's disease, and motoneurone disease: abiotrophic interaction between ageing and environment?
Lancet 1986;2(8515):1067-70.
-
1986: Tsui J K; Eisen A; Stoessl A J; Calne S; Calne D B
Double-blind study of botulinum toxin in spasmodic torticollis.
Lancet 1986;2(8501):245-7.
-
1986: McGeer P L; Kamo H; Harrop R; Li D K; Tuokko H; McGeer E G; Adam M J; Ammann W; Beattie B L; Calne D B
Positron emission tomography in patients with clinically diagnosed Alzheimer's disease.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 1986;134(6):597-607.
-
1986: Bharucha N E; Stokes L; Schoenberg B S; Ward C; Ince S; Nutt J G; Eldridge R; Calne D B; Mantel N; Duvoisin R
A case-control study of twin pairs discordant for Parkinson's disease: a search for environmental risk factors.
Neurology 1986;36(2):284-8.
-
1986: Lau E; Waterman K; Glover R; Schulzer M; Calne D B
Effect of antacid on levodopa therapy.
Clinical neuropharmacology 1986;9(5):477-9.
-
1986: Bozek C B; Suchowersky O; Purves S; Calne S; Calne D B
Sinemet in Parkinson's disease: efficacy with and without food.
Clinical neuropharmacology 1986;9(2):196-9.
-
1986: Calne D B; Stoessl A J
Early parkinsonism.
Clinical neuropharmacology 1986;9 Suppl 2():S3-8.
-
1986: Calne D B; Rinne U K
Controversies in the management of Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1986;1(3):159-62.
-
1985: Stoessl A J; Mak E; Calne D B
(+)-4-Propyl-9-hydroxynaphthoxazine (PHNO), a new dopaminomimetic, in treatment of parkinsonism.
Lancet 1985;2(8468):1330-1.
-
1985: Tsui J K; Eisen A; Mak E; Carruthers J; Scott A; Calne D B
A pilot study on the use of botulinum toxin in spasmodic torticollis.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1985;12(4):314-6.
-
1985: Calne D B; Langston J W; Martin W R; Stoessl A J; Ruth T J; Adam M J; Pate B D; Schulzer M
Positron emission tomography after MPTP: observations relating to the cause of Parkinson's disease.
Nature 1985;317(6034):246-8.
-
1985: Burton K; Larsen T A; Robinson R G; Bratty P J; Martin W R; Schulzer M; Calne D B
Parkinson's disease: a comparison of mesulergine and bromocriptine.
Neurology 1985;35(8):1205-8.
-
1985: Newman R P; LeWitt P A; Jaffe M; Calne D B; Larsen T A
Motor function in the normal aging population: treatment with levodopa.
Neurology 1985;35(4):571-3.
-
1985: Larsen T A; Dunn H G; Jan J E; Calne D B
Dystonia and calcification of the basal ganglia.
Neurology 1985;35(4):533-7.
-
1985: Eisen A; Hoirch M; Fink M; Goya T; Calne D
Noninvasive measurement of central sensory and motor conduction.
Neurology 1985;35(4):503-9.
-
1985: Turnbull I M; McGeer P L; Beattie L; Calne D; Pate B
Stimulation of the basal nucleus of Meynert in senile dementia of Alzheimer's type. A preliminary report.
Applied neurophysiology 1985;48(1-6):216-21.
-
1985: Newman R P; LeWitt P A; Shults C; Bruno G; Foster N L; Chase T N; Calne D B
Dystonia: treatment with bromocriptine.
Clinical neuropharmacology 1985;8(4):328-33.
-
1984: Eisen A; Hoirch M; White J; Calne D
Sensory group Ia proximal conduction velocity.
Muscle & nerve 1984;7(8):636-41.
-
1984: Burton K; Calne D B
Pharmacology of Parkinson's disease.
Neurologic clinics 1984;2(3):461-72.
-
1984: Burton K; Farrell K; Li D; Calne D B
Lesions of the putamen and dystonia: CT and magnetic resonance imaging.
Neurology 1984;34(7):962-5.
-
1984: Larsen T A; Newman R; LeWitt P; Calne D B
Severity of Parkinson's disease and the dosage of bromocriptine.
Neurology 1984;34(6):795-7.
-
1984: Newman R P; Weingartner H; Smallberg S A; Calne D B
Effortful and automatic memory: effects of dopamine.
Neurology 1984;34(6):805-7.
-
1984: Eisen A; Burton K; Larsen A; Hoirch M; Calne D
A new indirect method for measuring spinal conduction velocity in man.
Electroencephalography and clinical neurophysiology 1984;59(3):204-13.
-
1984: Newman R P; Calne D B
Diagnosis and management of Parkinson's disease.
Geriatrics 1984;39(5):87-91, 94, 96.
-
1984: Burns R S; Gopinathan G; Hümpel M; Dorow R; Calne D B
Disposition of oral lisuride in Parkinson's disease.
Clinical pharmacology and therapeutics 1984;35(4):548-56.
-
1984: Calne D B
Progress in Parkinson's disease.
The New England journal of medicine 1984;310(8):523-4.
-
1984: Martin W R; Beckman J H; Calne D B; Adam M J; Harrop R; Rogers J G; Ruth T J; Sayre C I; Pate B D
Cerebral glucose metabolism in Parkinson's disease.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1984;11(1 Suppl):169-73.
-
1984: Ward C D; Trombley I K; Calne D B; Kopin I J
L-dopa decarboxylation in chronically treated patients.
Neurology 1984;34(2):198-201.
-
1984: Calne D B; Burton K; Beckman J; Martin W R
Dopamine agonists in Parkinson's disease.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1984;11(1 Suppl):221-4.
-
1984: Larsen T A; Calne S; Calne D B
Assessment of Parkinson's disease.
Clinical neuropharmacology 1984;7(2):165-9.
-
1984: Calne D B; Duvoisin R C; McGeer E
Speculations on the etiology of Parkinson's disease.
Advances in neurology 1984;40():353-60.
-
1984: Ward C D; Duvoisin R C; Ince S E; Nutt J D; Eldridge R; Calne D B; Dambrosia J
Parkinson's disease in twins.
Advances in neurology 1984;40():341-4.
-
1984: LeWitt P A; Miller L P; Newman R P; Burns R S; Insel T; Levine R A; Lovenberg W; Calne D B
Tyrosine hydroxylase cofactor (tetrahydrobiopterin) in parkinsonism.
Advances in neurology 1984;40():459-62.
-
1984: Burton K; Calne D B
Dopamine agonists and Parkinson's disease.
Clinical neurology and neurosurgery 1984;86(3):172-7.
-
1983: Calne D B; Langston J W
Aetiology of Parkinson's disease.
Lancet 1983;2(8365-66):1457-9.
-
1983: LeWitt P A; Newman R P; Greenberg H S; Rocher L L; Calne D B; Ehrenkranz J R
Episodic hyperhidrosis, hypothermia, and agenesis of corpus callosum.
Neurology 1983;33(9):1122-9.
-
1983: LeWitt P A; Ward C D; Larsen T A; Raphaelson M I; Newman R P; Foster N; Dambrosia J M; Calne D B
Comparison of pergolide and bromocriptine therapy in parkinsonism.
Neurology 1983;33(8):1009-14.
-
1983: Ward C D; Hess W A; Calne D B
Olfactory impairment in Parkinson's disease.
Neurology 1983;33(7):943-6.
-
1983: Ward C D; Duvoisin R C; Ince S E; Nutt J D; Eldridge R; Calne D B
Parkinson's disease in 65 pairs of twins and in a set of quadruplets.
Neurology 1983;33(7):815-24.
-
1983: Calne D B
Current views on Parkinson's disease.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1983;10(1):11-5.
-
1983: Ward C D; Sanes J N; Dambrosia J M; Calne D B
Methods for evaluating treatment in Parkinson's disease.
Advances in neurology 1983;37():1-7.
-
1983: LeWitt P A; Burns R S; Calne D B
Lisuride treatment in Parkinson's disease: clinical and pharmacokinetic studies.
Advances in neurology 1983;37():131-40.
-
1983: Larsen T A; Calne D B
Essential tremor.
Clinical neuropharmacology 1983;6(3):185-206.
-
1982: Karson C N; LeWitt P A; Calne D B; Wyatt R J
Blink rates in parkinsonism.
Annals of neurology 1982;12(6):580-3.
-
1982: Larsen T A; Teräväinen H; Calne D B
Atenolol vs. propranolol in essential tremor. A controlled, quantitative study.
Acta neurologica Scandinavica 1982;66(5):547-54.
-
1982: Karoum F; Chuang L W; Eisler T; Calne D B; Liebowitz M R; Quitkin F M; Klein D F; Wyatt R J
Metabolism of (-) deprenyl to amphetamine and methamphetamine may be responsible for deprenyl's therapeutic benefit: a biochemical assessment.
Neurology 1982;32(5):503-9.
-
1982: LeWitt P A; Gopinathan G; Ward C D; Sanes J N; Dambrosia J M; Durso R; Calne D B
Lisuride versus bromocriptine treatment in Parkinson disease: a double-blind study.
Neurology 1982;32(1):69-72.
-
1982: Calne D B
The role of various forms of treatment in the management of Parkinson's disease.
Clinical neuropharmacology 1982;5 Suppl 1():S38-43.
-
1981: Eisler T; Thorner M O; MacLeod R M; Kaiser D L; Calne D B
Prolactin secretion in Parkinson disease.
Neurology 1981;31(10):1356-9.
-
1981: Eisler T; Hall R P; Kalavar K A; Calne D B
Erythromelalgia-like eruption in parkinsonian patients treated with bromocriptine.
Neurology 1981;31(10):1368-70.
-
1981: Gopinathan G; Teräväinen H; Dambrosia J M; Ward C D; Sanes J N; Stuart W K; Evarts E V; Calne D B
Lisuride in parkinsonism.
Neurology 1981;31(4):371-6.
-
1981: Evarts E V; Teräväinen H; Calne D B
Reaction time in Parkinson's disease.
Brain : a journal of neurology 1981;104(Pt 1):167-86.
-
1981: Eisler T; Eng N; Plotkin C; Calne D B
Absorption of levodopa after rectal administration.
Neurology 1981;31(2):215-7.
-
1981: Duvoisin R C; Eldridge R; Williams A; Nutt J; Calne D
Twin study of Parkinson disease.
Neurology 1981;31(1):77-80.
-
1981: Eisler T; Teräväinen H; Nelson R; Krebs H; Weise V; Lake C R; Ebert M H; Whetzel N; Murphy D L; Kopin I J; Calne D B
Deprenyl in Parkinson disease.
Neurology 1981;31(1):19-23.
-
1981: Silbergeld E K; Calne D B
Animal models of parkinsonism.
Pharmacology & therapeutics 1981;12(1):159-66.
-
1981: Le Witt P A; Calne D B
Recent advances in the treatment of Parkinson's disease: the role of bromocriptine.
Journal of neural transmission 1981;51(1-2):175-84.
-
1981: Teräväinen H; Calne D B
Assessment of hypokinesia in Parkinsonism.
Journal of neural transmission 1981;51(1-2):149-59.
-
1980: Ward C; Karsh J; Calne D B
Cranial herpes zoster: a case report and a hypothesis.
Journal of neurology, neurosurgery, and psychiatry 1980;43(12):1146-7.
-
1980: Williams A; Ballenger J; Levine R; Lovenberg W; Calne D
Aging and CSF hydroxylase cofactor.
Neurology 1980;30(11):1244-6.
-
1980: Teräväinen H; Calne D B
Studies of parkinsonian movement: 2. Initiation of fast voluntary eye movement during postural disturbance.
Acta neurologica Scandinavica 1980;62(3):149-57.
-
1980: Teräväinen H; Calne D B
Studies of parkinsonian movement: 1. Programming and execution of eye movements.
Acta neurologica Scandinavica 1980;62(3):137-48.
-
1980: Gopinathan G; Calne D B
Incontinence of urine with long-term bromocriptine therapy.
Annals of neurology 1980;8(2):204.
-
1980: Williams A C; Levine R A; Chase T N; Lovenberg W; Calne D B
CFS hydroxylase cofactor levels in some neurological diseases.
Journal of neurology, neurosurgery, and psychiatry 1980;43(8):735-8.
-
1980: Teräväinen H; Calne D B
Action tremor in Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1980;43(3):257-63.
-
1980: Teychenne P F; Rosin A J; Plotkin C N; Calne D B
Cross tolerance between two dopaminergic ergot derivatives--bromocriptine and lergotrile.
British journal of clinical pharmacology 1980;9(1):47-50.
-
1980: Calne D B; Kebabian J K
Parkinson's disease: unanswered questions.
Journal of neural transmission. Supplementum 1980;(16):1-5.
-
1980: Calne D B; Eisler T; Gopinathan G; Williams A
Progress in the pharmacotherapy of Parkinsonism.
Advances in biochemical psychopharmacology 1980;23():237-43.
-
1979: Neophytides A N; Teychenne P F; Pfeiffer R F; Calne D B
Sodium valproate in the treatment of cerebellar disorders.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1979;6(4):455-7.
-
1979: Calne D B
Neurotransmitters, neuromodulators, and neurohormones.
Neurology 1979;29(11):1517-21.
-
1979: Williams A; Houff S; Lees A; Calne D B
Oligoclonal banding in the cerebrospinal fluid of patients with postencephalitic Parkinsonism.
Journal of neurology, neurosurgery, and psychiatry 1979;42(9):790-2.
-
1979: Nutt J; Williams A; Plotkin C; Eng N; Ziegler M; Calne D B
Treatment of Parkinson's disease with sodium valproate: clinical, pharmacological, and biochemical observations.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1979;6(3):337-43.
-
1979: Calne D B; Eisler T
The pathogensis and medical treatment of extrapyramidal disease.
The Medical clinics of North America 1979;63(4):715-27.
-
1979: Teräväinen H; Calne D B
Developments in understanding the physiology and pharmacology of parkinsonism.
Acta neurologica Scandinavica 1979;60(1):1-11.
-
1979: Lovenberg W; Levine R A; Robinson D S; Ebert M; Williams A C; Calne D B
Hydroxylase cofactor activity in cerebrospinal fluid of normal subjects and patients with Parkinson's disease.
Science (New York, N.Y.) 1979;204(4393):624-6.
-
1979: Teychenne P F; Jones E A; Ishak K G; Calne D B
Hepatocellular injury with distinctive mitochondrial changes induced by lergotrile mesylate: a dopaminergic ergot derivative.
Gastroenterology 1979;76(3):575-83.
-
1979: Williams A; Hanson D; Calne D B
Vocal cord paralysis in the Shy-Drager syndrome.
Journal of neurology, neurosurgery, and psychiatry 1979;42(2):151-3.
-
1979: Calne D B; Kebabian J; Silbergeld E; Evarts E
Advances in the neuropharmacology of Parkinsonism.
Annals of internal medicine 1979;90(2):219-29.
-
1979: Rosin A J; Devereux D; Eng N; Calne D B
Parkinsonism with 'on-off' phenomena. Intravenous treatment with levodopa after major abdominal surgery.
Archives of neurology 1979;36(1):32-4.
-
1979: Kebabian J W; Calne D B
Multiple receptors for dopamine.
Nature 1979;277(5692):93-6.
-
1979: Fahn S; Barbeau A; Calne D; Duvoisin R; Markham C; Paulson G
Symposium I: Therapeutic controversies in movement disorders.
Transactions of the American Neurological Association 1979;104():31-51.
-
1978: Nutt J G; Rosin A J; Eisler T; Calne D B; Chase T N
Effect of an opiate antagonist on movement disorders.
Archives of neurology 1978;35(12):810-1.
-
1978: Calne D B; Williams A C; Nutt J G; Neophytides A; Eisler T; Teychenne P F
Ergot derivatives for Parkinsonism.
The Medical journal of Australia 1978;2(3 Suppl):25-6.
-
1978: Calne D B
Parkinsonism. Clinical and neuropharmacologic aspects.
Postgraduate medicine 1978;64(2):82-8.
-
1978: Calne D B
Role of ergot derivatives in the treatment of parkinsonism.
Federation proceedings 1978;37(8):2207-9.
-
1978: Teychenne P F; Pfeiffer R F; Bern S M; McInturff D; Calne D B
Comparison between lergotrile and bromocriptine in parkinsonism.
Annals of neurology 1978;3(4):319-24.
-
1978: Calne D B; Plotkin C; Williams A C; Nutt J G; Neophytides A; Teychenne P F
Long-term treatment of parkinsonism with bromocriptine.
Lancet 1978;1(8067):735-8.
-
1978: Fahn S; Calne D B
Considerations in the management of parkinsonism.
Neurology 1978;28(1):5-7.
-
1977: Teychenne P F; Pfeiffer R; Bern S M; Calne D B
Experiences with a new ergoline (CF 25-397) in parkinsonism.
Neurology 1977;27(12):1140-3.
-
1977: Silbergeld E K; Adler H; Kennedy S; Calne D B
The roles of presynaptic function and hepatic drug metabolism in the hypothermic actions of two novel dopaminergic agonists.
The Journal of pharmacy and pharmacology 1977;29(10):632-5.
-
1977: Calne D B
Antiparkinsonian therapy.
Primary care 1977;4(3):533-9.
-
1977: Calne D B
Developments in the pharmacology and therapeutics of parkinsonism.
Annals of neurology 1977;1(2):111-9.
-
1977: Calne D B; Teychenne P F; Pfeiffer R F
Treatment of parkinsonism.
Advances in experimental medicine and biology 1977;90():49-61.
-
1977: Calne D B; Teychenne P F
L-DOPA effect on blood pressure in man.
Progress in brain research 1977;47():331-6.
-
1977: Kebabian J W; Calne D B; Kebabian P R
Lergotrile mesylate: an in vivo dopamine agonist which blocks dopamine receptors in vitro.
Communications in psychopharmacology 1977;1(4):311-8.
-
1976: Calne D B
Developments in the treatment of parkinsonism.
The New England journal of medicine 1976;295(25):1433-4.
-
1976: Teychenne P F; Park D M; Findley L J; Rose F C; Calne D B
Nomifensine in parkinsonism.
Journal of neurology, neurosurgery, and psychiatry 1976;39(12):1219-21.
-
1976: Walters I N; Teychenne P F; Claveria L E; Calne D B
Penicillin transport from cerebrospinal fluid.
Neurology 1976;26(11):1008-10.
-
1976: Kartzinel R; Shoulson I; Calne D B
Studies with bromocriptine: III. Concomitant administration of caffeine to patients with idiopathic parkinsonism.
Neurology 1976;26(8):741-3.
-
1976: Kartzinel R; TEYCHENNE P; Gillespie M M; Perlow M; Gielen A C; Sadowsky D A; Calne D B
Bromocriptine and levodopa (with or without carbidopa) in parkinsonism.
Lancet 1976;2(7980):272-5.
-
1976: Kartzinel R; Hunt R D; Calne D B
Bromocriptine in Huntington chorea.
Archives of neurology 1976;33(7):517-8.
-
1976: Teychenne P F; Walters I; Claveria L E; Calne D B; Price J; Macgillivary B B; Gompertz D
The encephalopathic action of five-carbon-atom fatty acids in the rabbit.
Clinical science and molecular medicine 1976;50(6):463-72.
-
1976: Kartznel R; Calne D B
Studies with bromocriptine. Part 1. "On-off" phenomena.
Neurology 1976;26(6 PT 1):508-10.
-
1976: Kartzinel R; Shoulson I; Calne D B
Studies with bromocriptine. Part 2. Double-blind comparison with levodopa in idiopathic parkinsonism.
Neurology 1976;26(6 PT 1):511-3.
-
1976: Calne D B; Fermaglich J
Gout induced by L-dopa and decarboxylase inhibitors.
Postgraduate medical journal 1976;52(606):232-3.
-
1976: Amico D J; Calne D B; Klawans H L
Altered hypothermic responsivness to (+)-amphetamine.
The Journal of pharmacy and pharmacology 1976;28(2):154-6.
-
1976: Teychenne P F; Kartzinel R; Perlow M; Pfeiffer R; Calne D B
Clinical studies with bromocriptine in idiopathic parkinsonism.
Transactions of the American Neurological Association 1976;101():302-4.
-
1976: Calne D B; Shoulson I; Kartzinel R
An ergot derivative in the treatment of Parkinson's disease.
Postgraduate medical journal 1976;52suppl 1():81-5.
-
1976: Kartzinel R; Perlow M D; Carter A C; Chase T N; Calne D B; Shoulson I
Metabolic studies with bromocriptine in patients with idiopathic parkinsonism and Huntington's chorea.
Transactions of the American Neurological Association 1976;101():53-6.
-
1975: Teychenne P F; Calne D B; Lewis P J; Findley L J
Interactions of levodopa with inhibitors of monoamine oxidase and L-aromatic amino acid decarboxylase.
Clinical pharmacology and therapeutics 1975;18(3):273-7.
-
1975: Teychenne P F; Leigh P N; Reid J L; Calne D B; Greenacre J K; Petrie A; Bamji A N
Idiopathic parkinsonism treated with bromocriptine.
Lancet 1975;2(7933):473-6.
-
1975: Calne D B; Claveria L E; Reid J L
Hypothermic action of bromocriptine.
British journal of pharmacology 1975;54(1):123-4.
-
1975: Claveria L E; Teychenne P F; Calne D B; Haskayne L; Petrie A; Pallis C A; Lodge-Patch I C
Tardive dyskinesia treated with pimozide.
Journal of the neurological sciences 1975;24(4):393-401.
-
1975: Aminoff M J; Gross M; Laatz B; Vakil S D; Petrie A; Calne D B
Arterial blood pressure in patients with Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1975;38(1):73-7.
-
1975: Sandler M; Fellows L E; Calne D B; Findley L J
Letter: Oxprenolol and levodopa in parkinsonian patients.
Lancet 1975;1(7899):168.
-
1975: Calne D B
Drug treatment of spasticity and rigidity.
Modern trends in neurology 1975;6():205-21.
-
1975: Claveria L E; Teychenne P F; Calne D B; Petrie A; Bassendine M F
Dopaminergic agonists in Parkinsonism.
Advances in neurology 1975;9():383-92.
-
1974: Calne D B; Teychenne P F; Leigh P N; Bamji A N; Greenacre J K
Treatment of parkinsonism with bromocriptine.
Lancet 1974;2(7893):1355-6.
-
1974: Calne D B; Teychenne P F; Claveria L E; Eastman R; Greenacre J K; Petrie A
Bromocriptine in Parkinsonism.
British medical journal 1974;4(5942):442-4.
-
1974: Thomas P K; Calne D B; Stewart G
Hereditary motor and sensory polyneuropathy (peroneal muscular atrophy).
Annals of human genetics 1974;38(2):111-53.
-
1974: Sandler M; Johnson R D; Ruthven C R; Reid J L; Calne D B
Transamination is a major pathway of L-dopa metabolism following peripheral decarboxylase inhibition.
Nature 1974;247(440):364-6.
-
1974: Thomas P K; Calne D B
Motor nerve conduction velocity in peroneal muscular atrophy: evidence for genetic heterogeneity.
Journal of neurology, neurosurgery, and psychiatry 1974;37(1):68-75.
-
1974: Calne D B; Claveria L E; Teychenne P F; Haskayne L; Lodge-Patch I C
Pimozide in tardive dyskinesia.
Transactions of the American Neurological Association 1974;99():166-70.
-
1973: Calne D B; Reid J L
Actions of levodopa on the blood pressure of conscious rabbits.
British journal of pharmacology 1973;48(2):194-7.
-
1973: Claveria L E; Calne D B; Allen J G
"On-off" phenomena related to high plasma levodopa.
British medical journal 1973;2(5867):641-3.
-
1973: Calne D B; Reid J L; Vakil S D
Parkinsonism treated with 3-O-methyldopa.
Clinical pharmacology and therapeutics 1973;14(3):386-9.
-
1973: Calne D B; Reid J L
Action of levodopa on the blood pressure of conscious rabbits.
Clinical science 1973;44(4):18P.
-
1973: Bevan D R; Monks P S; Calne D B
Cardiovascular reactions to anaesthesia during treatment with levodopa.
Anaesthesia 1973;28(1):29-31.
-
1972: Reid J L; Calne D B; George C F; Vakil S D
The action of L(-)-dopa on baroreflexes in Parkinsonism.
Clinical science 1972;43(6):851-9.
-
1972: Calne D B; George C F; Reid J L; Vakil S D
Changes in baroreflexes induced by L-dopa.
British journal of pharmacology 1972;46(3):539P.
-
1972: Rao S K; Vakil S D; Calne D B; Hilson A
Augmenting the action of levodopa.
Postgraduate medical journal 1972;48(565):653-6.
-
1972: Reid J L; Calne D B; George C F; Vakil S D
Circulatory effects of intravenous tyramine and noradrenalin in Parkinsonism.
The Journal of clinical pharmacology and new drugs 1972;12(11):465-71.
-
1972: Reid J L; Calne D B; Vakil S D; Allen J G; Davies C A
Plasma concentration of levodopa in Parkinsonism before and after inhibition of peripheral decarboxylase.
Journal of the neurological sciences 1972;17(1):45-51.
-
1972: Reid J L; Calne D B; George C F; Vakil S D
Levodopa and pressor amine sensitivity in parkinsonism.
Clinical pharmacology and therapeutics 1972;13(3):400-6.
-
1972: Thomas P K; Calne D B; Elliott C F
X-linked scapuloperoneal syndrome.
Journal of neurology, neurosurgery, and psychiatry 1972;35(2):208-15.
-
1972: Calne D B; Petrie A; Rao S; Reid J L; Vakil S D
Action of L- -methyldopa-hydrazine on the blood pressure of patients receiving levodopa.
British journal of pharmacology 1972;44(1):162-4.
-
1972: Thomas P K; Calne D B; King R H
Autosomal dominant forms of hereditary hypertrophic neuropathy.
Monographs in human genetics 1972;6():210.
-
1972: Calne D B; Reid J L
Antiparkinsonian drugs: pharmacological and therapeutic aspects.
Drugs 1972;4(1):49-74.
-
1971: Calne D B
L-dopa and parkinsonism.
Nursing mirror and midwives journal 1971;133(15):26-7.
-
1971: Allen J G; Calne D B; Davies C A; Reid J L
Relationship of plasma concentrations of levodopa to clinical response in Parkinsonsim.
British journal of pharmacology 1971;43(2):464P-465P.
-
1971: Calne D B; Reid J L; Vakil S D; Rao S; Petrie A; Pallis C A; Gawler J; Thomas P K; Hilson A
Idiopathic Parkinsonism treated with an extracerebral decarboxylase inhibitor in combination with levodopa.
British medical journal 1971;3(5777):729-32.
-
1971: Reid J L; Calne D B; George C F; Pallis C; Vakil S D
Cardiovascular reflexes in Parkinsonism.
Clinical science 1971;41(1):63-7.
-
1971: Spiers A S; Calne D B; Vakil S D; French T M
Action of thymoxamine on mydriasis induced by levodopa and dopamine.
British medical journal 1971;2(5759):438-9.
-
1971: Reid J L; Calne D B; George C F; Vakil S D
Cardiovascular reflex activity in Parkinsonism.
Clinical science 1971;40(2):6P-7P.
-
1970: Pallis C A; Calne D B
Parkinsonism and cardiac arrhythmias.
Lancet 1970;2(7686):1313.
-
1970: Calne D B
L-Dopa in the treatment of parkinsonism.
Clinical pharmacology and therapeutics 1970;11(6):789-801.
-
1970: Calne D B; Shaw D G; Spiers A S; Stern G M
Swallowing in Parkinsonism.
The British journal of radiology 1970;43(511):456-7.
-
1970: Spiers A S; Calne D B; Fayers P M
Miosis during L-dopa therapy.
British medical journal 1970;2(5710):639-40.
-
1970: Calne D B; French T M; Spiers A S
The effects of dopamine, L-dopa, L-tyrosine, and pyridoxine on sympathetic nerve endings in man.
British journal of pharmacology 1970;39(1):195P-196P.
-
1970: Calne D B; Sandler M
L-Dopa and Parkinsonism.
Nature 1970;226(5240):21-4.
-
1970: Calne D B; Brennan J; Spiers A S; Stern G M
Hypotension caused by L-dopa.
British medical journal 1970;1(5694):474-5.
-
1969: Sandler M; Karoum F; Ruthven C R; Calne D B
m-Hydroxyphenylacetic acid formation from L-dopa in man: suppression by neomycin.
Science (New York, N.Y.) 1969;166(911):1417-8.
-
1969: Spiers A S; Calne D B
Action of dopamine on the human iris.
British medical journal 1969;4(5679):333-5.
-
1969: Calne D B; Stern G M; Spiers A S; Laurence D R
L-dopa in idiopathic parkinsonism.
Lancet 1969;2(7628):973-6.
-
1969: Calne D B; Webster R A
Tremor induced by tetrabenazine.
British journal of pharmacology 1969;37(2):468-75.
-
1969: Calne D B; Karoum F; Ruthven C R; Sandler M
The metabolism of orally administered L-Dopa in Parkinsonism.
British journal of pharmacology 1969;37(1):57-68.
-
1969: Calne D B; Stern G M; Laurence D R; Sharkey J; Armitage P
L-dopa in postencephalitic parkinsonism.
Lancet 1969;1(7598):744-6.
-
1969: Calne D B; Lader M H
Electromyographic studies of tremor using an averaging computer.
Electroencephalography and clinical neurophysiology 1969;26(1):86-92.
-
1968: Calne D B
Examination of the time relations of electrical activity in different muscle groups during tremor.
The Journal of physiology 1968;197(1):12P-14P.
-
1966: Calne D B; Pallis C A
Vibratory sense: a critical review.
Brain : a journal of neurology 1966;89(4):723-46.
-
1966: Calne D B; Raftery E B
Patent ductus arteriosus in an elderly man.
British heart journal 1966;28(5):716-7.
-
1966: Calne D B
Hypotension after exercise.
British medical journal 1966;1(5483):338-9.
-
1963: CALNE D B; LEIBOWITZ S
Suppression of experimental allergic encephalomyelitis by cytotoxic drugs.
Nature 1963;197():1309-10.
-
1959: CALNE D B
Pathways converging upon Purkinje cells in the frog's cerebellum.
The Journal of physiology 1959;146(3):459-64.
Sign-in to see more
